Month: March 2023

NEW YORK, March 14, 2023 (GLOBE NEWSWIRE) — AB International Group Corp. (OTC: ABQQ), an intellectual property (IP) and movie investment and licensing firm today announced NFT Movie and Music Marketplace License business updates. AB granted to the operator a worldwide license to a NFT movie music marketplace (the “NFT MMM”), AB consistently generated revenue from license fee monthly since August 2022. On March 13, 2023, AB signed an agreement with a digital crypto assets management operator. AB granted to the management company a worldwide license to a NFT movie music marketplace (the “NFT MMM”). AB will be additional income from the issuer annual fee beside fix monthly license fee. Under the agreement AB will generate $1.1 million to $2 million annual revenue, AB is developing enhance function version. AB plans continue partnership...

Uqoud Has Integrated Knomi®, Aware’s Industry-Leading Mobile Biometric Authentication Framework, Into its Contract Management Platform BURLINGTON, Mass., March 14, 2023 (GLOBE NEWSWIRE) — Aware, Inc. (NASDAQ: AWRE) today announced a new partnership with Middle East-based contract management platform provider Uqoud to integrate Knomi®, Aware’s industry-leading mobile biometric authentication framework, into the Uqoud platform. As a new part of Uqoud’s contract management platform, Knomi will enable Uqoud to onboard new users remotely using facial biometrics and identity verification and also continuously authenticate users through facial biometrics. This integration will empower Uqoud users to securely verify the identity of all stakeholders involved in contract signings with minimal friction. “Aware’s partnership with Uqoud represents...

Los Gatos, Calif., March 14, 2023 (GLOBE NEWSWIRE) — Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company, today announced that it has entered into a definitive agreement for the issuance and sale of an aggregate of 6,000,000 shares of the Company’s common stock at a purchase price of $0.38 per share in a registered direct offering. The closing of the offering is expected to occur on or about March 16, 2023, subject to the satisfaction of customary closing conditions. H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering. The gross proceeds to the Company from the offering are expected to be $2.28 million, before deducting the placement agent’s fees and other offering expenses payable by the Company. Aridis Pharmaceuticals currently intends to use the net proceeds from the offering...

Professor Kranzler is the Benjamin Rush Professor of Psychiatry and Director of the Center for Studies of Addiction at the University of Pennsylvania’s Perelman School of Medicine Tel Aviv, Israel / Vancouver, Canada, March 14, 2023 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (CSE: CMND), (FSE: CWY) (“Clearmind” or the “company”), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, today announced the appointment of Professor Henry R. Kranzler, M.D., as the newest member of its Scientific Advisory Board (“SAB”). Professor Kranzler is the Benjamin Rush Professor of Psychiatry, and Director of the Center for Studies of Addiction, at the University of Pennsylvania’s Perelman School of Medicine, which was...